Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Effector, Ignyta, and More 05/23/13 San Diego
Big Data Is BS in Healthcare. When Will It Become Real? 04/15/13 National
Crescendo Bioscience Snags $28M For Arthritis Test 01/03/13 San Francisco
Innovimmune Pursues Pharma Partners, Shuns VCs 08/07/12 New York
Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs 04/19/12 Seattle
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
Crescendo Bioscience Takes Arthritis Into the World of Hard Data 02/24/12 San Francisco
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs 01/26/12 Boston
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science 09/07/11 Seattle
Sanofi Collaboration Drives Regeneron’s Transformation From R&D House to Commercial Player 07/13/11 New York
Allozyne’s Backdoor IPO, Sound Pharma Fights iPod Deafness, Mirina Vs. Marina Ends, & More Seattle-Area Life Sciences News 06/23/11 Seattle
Pfizer Adds to Data on Novel RA Drug 04/28/11 New York
BG Medicine Chief Speaks on Rough IPO Climate, (Finally) Going Public 04/21/11 Boston
Pfizer Releases Top Line Data on Novel RA Drug 04/15/11 New York
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London 03/09/11 Seattle
Diagnostics Are Warming Up in Era of Fast, Cheap Sequencing, Says MDV’s Rowan Chapman 02/07/11 San Francisco
Acceleron Pharma Cuts 40 Percent of Workforce 11/03/10 Boston
Via Science Forms to Launch “Big Data” Analytics Startups 11/02/10 Boston
Montgomery Joins Alder Board 11/01/10 Seattle
Amylin Regroups From FDA Smackdown, CalciMedica Plans Trial of New Anti-Immune Drug, FDA Gives CareFusion Recall Highest Priority, & More San Diego Life Science News 10/21/10 San Diego
CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis 10/20/10 San Diego
Rigel Nabs $25M From AstraZeneca 09/29/10 San Francisco
Rigel Arthritis Drug Passes Trial 09/23/10 San Francisco
Cytomx, Backed by Third Rock & Roche, Raises $30M for New Class of Antibodies 09/23/10 San Francisco
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology 07/15/10 Boston
Femta Pharmaceuticals Snags $2.2M for Potent Antibody Drugs 07/13/10 San Diego
Gilead Buys CGI for Up To $120M 06/25/10 San Francisco
Pfizer Dumps Trubion’s Lead Rheumatoid Arthritis Drug, Keeps Next-Gen Product Alive 06/14/10 Seattle
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
Alder, Bristol Arthritis Drug Shows “Outstanding” Results in Trial, Lead Researcher Says 05/17/10 Seattle
Page 1 of 3 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.